Novo Nordisk Goodwill and Intangible Assets 2010-2024 | NVO

Novo Nordisk goodwill and intangible assets for the quarter ending June 30, 2024 were $8.009B, a 8.02% increase year-over-year.

  • Novo Nordisk goodwill and intangible assets for 2023 were $8.771B, a 20.47% increase from 2022.
  • Novo Nordisk goodwill and intangible assets for 2022 were $7.281B, a 6% increase from 2021.
  • Novo Nordisk goodwill and intangible assets for 2021 were $6.869B, a 117.04% increase from 2020.

Novo Nordisk Goodwill and Intangible Assets 2010-2024 | NVO

  • Novo Nordisk goodwill and intangible assets for 2023 were $8.771B, a 20.47% increase from 2022.
  • Novo Nordisk goodwill and intangible assets for 2022 were $7.281B, a 6% increase from 2021.
  • Novo Nordisk goodwill and intangible assets for 2021 were $6.869B, a 117.04% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Pfizer (PFE)$168.6B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B